Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

DRUG: Nimotuzumab
DRUG: mFOLFIRINOX
DRUG: GX

PHASE2

Phase

RECRUITING

Status

Enrollment

OTHER

Sponsor class

Conditions

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School